Topic
astrazeneca
3 stories, newest first.
- Business & Economy · United States
AstraZeneca offers $10 billion for Rhythm Pharmaceuticals
AstraZeneca has made a non-binding offer of approximately $10 billion to acquire Rhythm Pharmaceuticals, a company specializing in treatments for rare forms of obesity. The offer values Rhythm at about $124 per share, including potential milestone payments.
United States2 min readTrust 53 · Craft 87 · Hype 15 
Science & Tech · Middle EastAstraZeneca and Oracle Partner on AI for Clinical Research
Pharmaceutical giant AstraZeneca is teaming up with technology firm Oracle to leverage artificial intelligence and real-world data. The partnership seeks to enhance clinical research by improving patient recruitment for trials and monitoring safety signals, with initial efforts focused on several key disease areas.
Middle East3 min readTrust 42 · Craft 61 · Hype 20
Health · United KingdomNurse denied vaccine compensation due to recovery
A nurse who developed transverse myelitis after an AstraZeneca COVID-19 vaccine has been denied compensation because her condition has improved. The Vaccine Damage Payment Scheme requires a 60% disability threshold, which Marie-Claire Hoyle no longer meets.
United Kingdom3 min readTrust 50 · Craft 45 · Hype 40